Latest Breaking News On - Investor relations corporate communications - Page 16 : comparemela.com

Aligos Therapeutics Mourns the Passing of MASH Industry Leader Stephen A. Harrison, MD

SOUTH SAN FRANCISCO, Calif., April 25, 2024 Aligos Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in.

Fusion Pharmaceuticals Mails Circular for Special Meeting of Shareholders and Announces Receipt of Interim Order

/PRNewswire/ Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radioconjucates (RCs) as.

Fusion Pharmaceuticals Mails Circular for Special Meeting of Shareholders and Announces Receipt of Interim Order

HAMILTON, ON and BOSTON, April 25, 2024 /PRNewswire/ Fusion Pharmaceuticals Inc. , a clinical-stage oncology company focused on developing next-generation radioconjucates as precision medicines,.

EQS-News: Blue Cap AG publishes 2023 annual report and proposes dividend of EUR 0.65 per share

Blue Cap AG publishes 2023 annual report and proposes dividend of EUR 0.65 per share

EQS-News: Blue Cap AG / Key word: Annual Report/Dividend Blue Cap AG publishes 2023 annual report and proposes dividend of EUR 0.65 per share 24.04.2024 / 07:09.